NEW YORK (GenomeWeb News) — Former Applied Biosystems President Cathy Burzik has been named to the board of directors at Bausch & Lomb.
Burzik left ABI in October 2006 to become CEO at the medical company Kinetic.
Sequenom has named Paul Hawran its new CFO, the company said this week.
Hawran has resigned his position on the company’s board but will serve as a consultant to the company until April 1.
Chairman Harry Hixson will replace Hawran on the audit committee.
Hawran formerly was CFO of Neurocrine Biosciences and served as finance director at Warner Communications, and was vice president and treasurer at SmithKline Beecham.
CombiMatrix’s Molecular Diagnostics subsidiary this week said CEO Matt Watson will step down and will be replaced by Mansoor Mohammed, who is currently president and COO. Watson will stay on with the company for three months as a consultant.
Bio-Rad this week appointed Louis Drapeau to its audit committee. He will stand for election at a board meeting in April. Drapeau fills the space left open by the death late last year of Philip Padou.
Drapeau is currently CFO and senior vice president of finance at Nextar Therapeutics. He also served as CEO, CFO, and senior vice president at BioMarin Pharmaceutical, and was an executive in accounting and he serves on the board of directors at Inflazyme Pharmaceuticals.
PerkinElmer this week has appointed Richard Begley vice president and general manager of its Analytical Sciences business.
In this position, Begley will “develop and lead the growth strategy” globally for the firm’s entire portfolio of analytical instrumentation, which includes chromatography, atomic and molecular spectroscopy, thermal analysis, and laboratory information management systems.
Begley joins PerkinElmer from Ensemble Discovery, where he was president and CEO. Before this he was CEO and president of 454 Life Sciences.
Robert Ellis has been elected to the board of directors at SciGene, the company said this week. Ellis is currently executive chairman of Biotrove, where he was formerly CEO and president.
Ellis also was vice president of R&D at Affymetrix and was a senior manager at Genometrix, Applied Biosystems, PerkinElmer and Hewlett Packard.
MDS this week said it has promoted Douglas Prince to be its new CFO and executive vice president of finance.
Prince recently was involved in risk management and internal auditing at PerkinElmer, where he also served as vice president and CFO. Prince also worked in the financial departments at General Electric and at AlliedSignal.
BioMicro Systems has named Rob Parry vice president of manufacturing, the company said this week.
In the position, Parry will be responsible for expanding manufacturing capacity for the company’s hybridization system products.
Parry formerly worked in manufacturing at Nanosys; was vice president of manufacturing at Fluidigm; and worked in Agilent Technologies’ microarray business.
William Clarke has been named to Caden Biosciences’ board of directors, the company said this week.
Clarke is CEO of Cellectar, and recently was executive vice president and chief technology officer and chief medical officer at GE Healthcare.
Prior to that, Clarke also was a vice president at Amersham Health and was a director of biological sciences at Glaxo Wellcome UK.
Epiphany Biosciences said last week it has appointed Roger Kornberg to its scientific advisory board. Kornberg is a professor of structural biology and medicine at the Stanford University School of Medicine, where his research is focused on understanding gene regulation.
Kornberg was awarded the 2006 Nobel Prize in Chemistry for his research on eukaryotic transcription, including the discovery of the mediator gene transcription protein complex and the solution of the three-dimensional crystal structure of RNA polymerase II.
Kornberg did his postdoctoral studies with Aaron Klug and Francis Crick at the Medical Research Council Laboratory of Molecular Biology in Cambridge, UK, where he discovered the nucleosome.
Eric Lander, director of the Broad Institute of MIT and Harvard, has received the 2007 Society for Biomolecular Sciences Achievement Award for Innovation in HTS, the group said this week. Lander will receive his award during a presentation at the Society for Biomolecular Science’s 13th Annual Conference & Exhibition in Montreal, Canada, which will be held on April 15-19.
The Award recognizes “outstanding achievements in research, innovation, groundbreaking foundation or seminal contributions that have proven to be broadly applicable to biomolecular sciences or pharmaceutical/agricultural lead discovery.”
Lander will receive a $5,000 honorarium.
Past recipients of the SBS Award include Applied Biosystems’ Mike Hunkapiller and Lee Hood from the Institute for Systems Biology.